FindTrial
Sign In

fasting serum magnesium level changes in type 2 diabetes mellitus

A cross sectional study on fasting serum magnesium levels and its association with glycated hemoglobin in Samprapti of madhumeha With reference to type 2 diabetes mellitus - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/12/078123
Enrollment
100
Registered
2024-12-16
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

Government Ayurveda medical College BANGALORE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient between the age of 30-70 years. Patient should have the classical sign and symptoms of madhumeha. Patient should have 5 year history of type 2 diabetes mellitus.

Exclusion criteria

Exclusion criteria: Gestational diabetes Chronic kidney disease Hereditary anemias The disease that affecting the serum magnesium level other than type 2 diabetes mellitus

Design outcomes

Primary

MeasureTime frame
Assessment of of fasting serum magnesium levels and association with glycated hemoglobin in madhumehaTimepoint: Nil—

Secondary

MeasureTime frame
To observe the fasting serum magnesium in madhumeha for early diagnosis and better treatment application.Timepoint: Nil—

Countries

India

Contacts

Public ContactDr Afnan Naaz

Government Ayurveda medical College Bangalore

dr.shivpav@gmail.com9035180132

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026